Rank | Gene Set | Z-score |
---|---|---|
1 | presynaptic membrane organization (GO:0097090) | 5.87366129 |
2 | presynaptic membrane assembly (GO:0097105) | 5.80853780 |
3 | axonemal dynein complex assembly (GO:0070286) | 5.77894045 |
4 | regulation of synapse structural plasticity (GO:0051823) | 5.63907884 |
5 | neuron cell-cell adhesion (GO:0007158) | 5.21719967 |
6 | cilium movement (GO:0003341) | 5.02492273 |
7 | cilium or flagellum-dependent cell motility (GO:0001539) | 4.75536113 |
8 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 4.59622928 |
9 | behavioral response to ethanol (GO:0048149) | 4.53047416 |
10 | intraciliary transport (GO:0042073) | 4.51795237 |
11 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 4.50602167 |
12 | epithelial cilium movement (GO:0003351) | 4.26844284 |
13 | regulation of cilium movement (GO:0003352) | 4.23392999 |
14 | synaptic vesicle maturation (GO:0016188) | 4.23026991 |
15 | axon ensheathment in central nervous system (GO:0032291) | 4.19965472 |
16 | central nervous system myelination (GO:0022010) | 4.19965472 |
17 | motile cilium assembly (GO:0044458) | 4.19549562 |
18 | axoneme assembly (GO:0035082) | 4.19032712 |
19 | left/right pattern formation (GO:0060972) | 4.05594981 |
20 | synaptic vesicle exocytosis (GO:0016079) | 4.02664876 |
21 | negative regulation of neurotransmitter secretion (GO:0046929) | 4.00290236 |
22 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 3.98584943 |
23 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 3.93039794 |
24 | vocalization behavior (GO:0071625) | 3.89134448 |
25 | synaptic transmission, dopaminergic (GO:0001963) | 3.88942353 |
26 | GTP biosynthetic process (GO:0006183) | 3.88589215 |
27 | postsynaptic membrane organization (GO:0001941) | 3.87820099 |
28 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 3.77964784 |
29 | ATP synthesis coupled proton transport (GO:0015986) | 3.71622240 |
30 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 3.71622240 |
31 | ventricular system development (GO:0021591) | 3.70987537 |
32 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.68966114 |
33 | negative regulation of neurotransmitter transport (GO:0051589) | 3.68790088 |
34 | response to histamine (GO:0034776) | 3.66198714 |
35 | pyrimidine nucleobase catabolic process (GO:0006208) | 3.63808929 |
36 | short-term memory (GO:0007614) | 3.60825339 |
37 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 3.60254173 |
38 | neuronal action potential propagation (GO:0019227) | 3.57529236 |
39 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 3.56448888 |
40 | positive regulation of dendritic spine development (GO:0060999) | 3.55414197 |
41 | nucleoside diphosphate phosphorylation (GO:0006165) | 3.52783284 |
42 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 3.52720114 |
43 | glutamate secretion (GO:0014047) | 3.48492403 |
44 | positive regulation of inositol phosphate biosynthetic process (GO:0060732) | 3.45692912 |
45 | membrane hyperpolarization (GO:0060081) | 3.45520423 |
46 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.43369328 |
47 | neuron-neuron synaptic transmission (GO:0007270) | 3.41486217 |
48 | cilium organization (GO:0044782) | 3.39899649 |
49 | synaptic transmission, glutamatergic (GO:0035249) | 3.36335933 |
50 | behavioral response to cocaine (GO:0048148) | 3.36111299 |
51 | behavioral defense response (GO:0002209) | 3.34925544 |
52 | behavioral fear response (GO:0001662) | 3.34925544 |
53 | negative regulation of execution phase of apoptosis (GO:1900118) | 3.33265262 |
54 | cilium assembly (GO:0042384) | 3.32785495 |
55 | UTP biosynthetic process (GO:0006228) | 3.27552246 |
56 | glutamate receptor signaling pathway (GO:0007215) | 3.27288903 |
57 | positive regulation of membrane potential (GO:0045838) | 3.22539710 |
58 | cilium morphogenesis (GO:0060271) | 3.21999707 |
59 | regulation of dopamine metabolic process (GO:0042053) | 3.20513300 |
60 | regulation of catecholamine metabolic process (GO:0042069) | 3.20513300 |
61 | regulation of glutamate receptor signaling pathway (GO:1900449) | 3.19778196 |
62 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.17483099 |
63 | purine ribonucleoside triphosphate biosynthetic process (GO:0009206) | 3.15500388 |
64 | protein localization to synapse (GO:0035418) | 3.11907837 |
65 | response to amphetamine (GO:0001975) | 3.10847211 |
66 | fear response (GO:0042596) | 3.10831976 |
67 | regulation of microtubule-based movement (GO:0060632) | 3.10306324 |
68 | transmission of nerve impulse (GO:0019226) | 3.09976169 |
69 | regulation of voltage-gated calcium channel activity (GO:1901385) | 3.09356091 |
70 | positive regulation of mitochondrial fission (GO:0090141) | 3.08839752 |
71 | regulation of catecholamine uptake involved in synaptic transmission (GO:0051940) | 3.08781809 |
72 | regulation of dopamine uptake involved in synaptic transmission (GO:0051584) | 3.08781809 |
73 | positive regulation of synapse assembly (GO:0051965) | 3.05450246 |
74 | nucleobase catabolic process (GO:0046113) | 3.05064595 |
75 | purine nucleoside triphosphate biosynthetic process (GO:0009145) | 3.04943901 |
76 | neuron recognition (GO:0008038) | 3.03518267 |
77 | respiratory electron transport chain (GO:0022904) | 3.02187187 |
78 | dopamine biosynthetic process (GO:0042416) | 3.00656908 |
79 | negative regulation of inclusion body assembly (GO:0090084) | 3.00175113 |
80 | chemosensory behavior (GO:0007635) | 2.97217056 |
81 | electron transport chain (GO:0022900) | 2.95921502 |
82 | protein complex biogenesis (GO:0070271) | 2.95185189 |
83 | long-chain fatty acid biosynthetic process (GO:0042759) | 2.94875850 |
84 | ATP biosynthetic process (GO:0006754) | 2.94617866 |
85 | microtubule bundle formation (GO:0001578) | 2.93962100 |
86 | detection of calcium ion (GO:0005513) | 2.93894735 |
87 | protein localization to cilium (GO:0061512) | 2.93448164 |
88 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 2.92883240 |
89 | UTP metabolic process (GO:0046051) | 2.92769355 |
90 | regulation of dendritic spine development (GO:0060998) | 2.92393189 |
91 | positive regulation of neurotransmitter transport (GO:0051590) | 2.92271040 |
92 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 2.91603304 |
93 | membrane assembly (GO:0071709) | 2.90725425 |
94 | dendritic spine morphogenesis (GO:0060997) | 2.88157422 |
95 | female mating behavior (GO:0060180) | 2.87896877 |
96 | left/right axis specification (GO:0070986) | 2.86231192 |
97 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 2.85411673 |
98 | CTP metabolic process (GO:0046036) | 2.83553643 |
99 | CTP biosynthetic process (GO:0006241) | 2.83553643 |
100 | positive regulation of sodium ion transmembrane transporter activity (GO:2000651) | 2.83508948 |
101 | ribonucleoside triphosphate biosynthetic process (GO:0009201) | 2.79971177 |
102 | neurotransmitter secretion (GO:0007269) | 2.76425461 |
103 | microtubule-based movement (GO:0007018) | 2.75735653 |
104 | regulation of postsynaptic membrane potential (GO:0060078) | 2.74872455 |
105 | axonal fasciculation (GO:0007413) | 2.73206326 |
106 | regulation of inositol phosphate biosynthetic process (GO:0010919) | 2.73123157 |
107 | establishment of mitochondrion localization (GO:0051654) | 2.72202219 |
108 | regulation of synaptic vesicle exocytosis (GO:2000300) | 2.71736978 |
109 | mitochondrial respiratory chain complex assembly (GO:0033108) | 2.70981178 |
110 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 2.70980871 |
111 | retinal ganglion cell axon guidance (GO:0031290) | 2.70921261 |
112 | regulation of protein kinase A signaling (GO:0010738) | 2.70413030 |
113 | nonribosomal peptide biosynthetic process (GO:0019184) | 2.69565771 |
114 | nonmotile primary cilium assembly (GO:0035058) | 2.68285482 |
115 | adenylate cyclase-activating dopamine receptor signaling pathway (GO:0007191) | 2.67204006 |
116 | regulation of neurotransmitter secretion (GO:0046928) | 2.66985315 |
117 | regulation of female receptivity (GO:0045924) | 2.66959947 |
118 | regulation of collateral sprouting (GO:0048670) | 2.66535407 |
119 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 2.66384123 |
120 | auditory behavior (GO:0031223) | 2.65839266 |
121 | mannosylation (GO:0097502) | 2.65360360 |
122 | regulation of neurotransmitter uptake (GO:0051580) | 2.64371221 |
123 | NADH dehydrogenase complex assembly (GO:0010257) | 2.63368166 |
124 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 2.63368166 |
125 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 2.63368166 |
126 | smoothened signaling pathway (GO:0007224) | 2.57146028 |
127 | neurofilament cytoskeleton organization (GO:0060052) | 2.57070394 |
128 | protein polyglutamylation (GO:0018095) | 2.56850736 |
129 | cellular component assembly involved in morphogenesis (GO:0010927) | 2.53946161 |
130 | neurotransmitter-gated ion channel clustering (GO:0072578) | 2.49562766 |
131 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 2.47004094 |
132 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.44349653 |
133 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.44075796 |
134 | determination of left/right symmetry (GO:0007368) | 2.41792379 |
135 | cytoskeleton-dependent intracellular transport (GO:0030705) | 2.41510781 |
136 | regulation of synaptic vesicle transport (GO:1902803) | 2.40520898 |
137 | dorsal/ventral neural tube patterning (GO:0021904) | 2.40304681 |
138 | response to auditory stimulus (GO:0010996) | 2.38386514 |
139 | behavioral response to nicotine (GO:0035095) | 2.37465655 |
140 | microtubule-based transport (GO:0010970) | 2.35388449 |
141 | synapse assembly (GO:0007416) | 2.31517126 |
142 | negative regulation of response to food (GO:0032096) | 2.31512736 |
143 | negative regulation of appetite (GO:0032099) | 2.31512736 |
144 | synaptic vesicle endocytosis (GO:0048488) | 2.31488927 |
145 | pyrimidine nucleotide catabolic process (GO:0006244) | 2.31118980 |
146 | retinal rod cell development (GO:0046548) | 2.30586217 |
147 | determination of bilateral symmetry (GO:0009855) | 2.30514130 |
148 | neuronal ion channel clustering (GO:0045161) | 2.30513746 |
149 | retinal cone cell development (GO:0046549) | 2.30285178 |
150 | glycosphingolipid biosynthetic process (GO:0006688) | 2.28784802 |
151 | ATP hydrolysis coupled proton transport (GO:0015991) | 2.28145135 |
152 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 2.28145135 |
153 | mechanosensory behavior (GO:0007638) | 2.26861028 |
154 | sperm capacitation (GO:0048240) | 2.25705743 |
155 | specification of symmetry (GO:0009799) | 2.25687724 |
156 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.25524373 |
Rank | Gene Set | Z-score |
---|---|---|
1 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.66403228 |
2 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 5.27832692 |
3 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.14482200 |
4 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 3.00347815 |
5 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.91042766 |
6 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.87995154 |
7 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.63219589 |
8 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.59369910 |
9 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.57231119 |
10 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.54470141 |
11 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.45876013 |
12 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.44228254 |
13 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.35250850 |
14 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.34672362 |
15 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.34672362 |
16 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 2.33420397 |
17 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.31486652 |
18 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.24384769 |
19 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 2.23669405 |
20 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.19508826 |
21 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.15270816 |
22 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.15099574 |
23 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.14352371 |
24 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 2.03970686 |
25 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.99211430 |
26 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.98204152 |
27 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.97552529 |
28 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.96203472 |
29 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.95707408 |
30 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.94686155 |
31 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.90004265 |
32 | FUS_26573619_Chip-Seq_HEK293_Human | 1.85894978 |
33 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.83287550 |
34 | P300_19829295_ChIP-Seq_ESCs_Human | 1.76811481 |
35 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.76357499 |
36 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.74658535 |
37 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.74221946 |
38 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.69470714 |
39 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.66553721 |
40 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.65398893 |
41 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.63830713 |
42 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.61831720 |
43 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.60870029 |
44 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.58905256 |
45 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.58806783 |
46 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.58568576 |
47 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.57461364 |
48 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.57278962 |
49 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.57264407 |
50 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.54384884 |
51 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.53126373 |
52 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.51780432 |
53 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.49700265 |
54 | SIN3B_21632747_ChIP-Seq_MESCs_Mouse | 1.48620929 |
55 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.48065430 |
56 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.47721736 |
57 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.46238700 |
58 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.37873251 |
59 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.34742128 |
60 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.33241301 |
61 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.31925391 |
62 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.27487202 |
63 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.27469210 |
64 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.27398863 |
65 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.24906564 |
66 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.24117427 |
67 | * NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.23113422 |
68 | VDR_22108803_ChIP-Seq_LS180_Human | 1.21967947 |
69 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.21256798 |
70 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.18631091 |
71 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.18386014 |
72 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.17950234 |
73 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.16176786 |
74 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 1.15851068 |
75 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 1.15786963 |
76 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.15700717 |
77 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.15269386 |
78 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.13824729 |
79 | AR_25329375_ChIP-Seq_VCAP_Human | 1.12943686 |
80 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.11950298 |
81 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.10945136 |
82 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.08671388 |
83 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.07913291 |
84 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.05479874 |
85 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.04885826 |
86 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.04779410 |
87 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.04522021 |
88 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.04360523 |
89 | * E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.02785887 |
90 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.00937427 |
91 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.00937427 |
92 | * CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.00857343 |
93 | * P53_22387025_ChIP-Seq_ESCs_Mouse | 1.00643735 |
94 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.00461658 |
95 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.00428047 |
96 | * STAT3_18555785_Chip-Seq_ESCs_Mouse | 0.98012681 |
97 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.98007570 |
98 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.97771667 |
99 | * SOX2_18555785_Chip-Seq_ESCs_Mouse | 0.97650079 |
100 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.97648604 |
101 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.97648604 |
102 | * SUZ12_18555785_Chip-Seq_ESCs_Mouse | 0.97477704 |
103 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.97336616 |
104 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.97193413 |
105 | * P300_18555785_Chip-Seq_ESCs_Mouse | 0.96123101 |
106 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 0.95757971 |
107 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 0.95731979 |
108 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.95572990 |
109 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.94795651 |
110 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.94518882 |
111 | TCF4_23295773_ChIP-Seq_U87_Human | 0.93734592 |
112 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.91902523 |
113 | KDM2B_26808549_Chip-Seq_REH_Human | 0.91353932 |
114 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.91164630 |
115 | ERA_21632823_ChIP-Seq_H3396_Human | 0.90888420 |
116 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.90833926 |
117 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.90572019 |
118 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 0.90073531 |
119 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.90060010 |
120 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 0.89623963 |
121 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.89372194 |
122 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 0.88426141 |
123 | STAT3_23295773_ChIP-Seq_U87_Human | 0.88334931 |
124 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 0.87635319 |
125 | * NMYC_18555785_Chip-Seq_ESCs_Mouse | 0.87029774 |
126 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.86938383 |
127 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 0.86406821 |
128 | NCOR_22424771_ChIP-Seq_293T_Human | 0.85643111 |
129 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 0.84681085 |
130 | * SETDB1_19884257_ChIP-Seq_MESCs_Mouse | 0.84363260 |
131 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.83592062 |
132 | EWS_26573619_Chip-Seq_HEK293_Human | 0.83455636 |
133 | WDR5_24793694_ChIP-Seq_LNCAP_Human | 0.81705517 |
134 | TP53_22573176_ChIP-Seq_HFKS_Human | 0.80516183 |
135 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 0.80427818 |
136 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 0.79857060 |
137 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 0.78898389 |
138 | MYC_18940864_ChIP-ChIP_HL60_Human | 0.78070574 |
139 | * CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 0.78021357 |
140 | AR_19668381_ChIP-Seq_PC3_Human | 0.77636650 |
141 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 0.77599972 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0003880_abnormal_central_pattern | 4.54845386 |
2 | MP0004859_abnormal_synaptic_plasticity | 3.83220380 |
3 | MP0003635_abnormal_synaptic_transmissio | 3.10508468 |
4 | MP0003136_yellow_coat_color | 3.10367713 |
5 | MP0009745_abnormal_behavioral_response | 2.96766464 |
6 | MP0002064_seizures | 2.70151689 |
7 | MP0006276_abnormal_autonomic_nervous | 2.69912340 |
8 | MP0003879_abnormal_hair_cell | 2.67337141 |
9 | MP0001984_abnormal_olfaction | 2.67190157 |
10 | MP0009046_muscle_twitch | 2.67002209 |
11 | MP0001968_abnormal_touch/_nociception | 2.59285566 |
12 | MP0009379_abnormal_foot_pigmentation | 2.50226486 |
13 | MP0001905_abnormal_dopamine_level | 2.45059003 |
14 | MP0002572_abnormal_emotion/affect_behav | 2.44623967 |
15 | MP0002272_abnormal_nervous_system | 2.44532476 |
16 | MP0002063_abnormal_learning/memory/cond | 2.44083966 |
17 | MP0005646_abnormal_pituitary_gland | 2.31426663 |
18 | MP0004270_analgesia | 2.24358686 |
19 | MP0003787_abnormal_imprinting | 2.24355628 |
20 | MP0001486_abnormal_startle_reflex | 2.23133785 |
21 | MP0005409_darkened_coat_color | 2.22469569 |
22 | MP0002734_abnormal_mechanical_nocicepti | 2.11338009 |
23 | MP0001440_abnormal_grooming_behavior | 2.09109615 |
24 | MP0001529_abnormal_vocalization | 2.05310146 |
25 | MP0001501_abnormal_sleep_pattern | 2.05201717 |
26 | MP0002736_abnormal_nociception_after | 2.03241331 |
27 | MP0006292_abnormal_olfactory_placode | 2.02115902 |
28 | MP0002909_abnormal_adrenal_gland | 1.97405853 |
29 | MP0005394_taste/olfaction_phenotype | 1.95440479 |
30 | MP0005499_abnormal_olfactory_system | 1.95440479 |
31 | MP0005410_abnormal_fertilization | 1.94710240 |
32 | MP0003283_abnormal_digestive_organ | 1.91691285 |
33 | MP0003690_abnormal_glial_cell | 1.90844790 |
34 | MP0003195_calcinosis | 1.87050637 |
35 | MP0005645_abnormal_hypothalamus_physiol | 1.85338032 |
36 | MP0003121_genomic_imprinting | 1.82466575 |
37 | MP0005423_abnormal_somatic_nervous | 1.77894772 |
38 | MP0008789_abnormal_olfactory_epithelium | 1.77526831 |
39 | MP0004742_abnormal_vestibular_system | 1.77288313 |
40 | MP0000778_abnormal_nervous_system | 1.71692802 |
41 | MP0002557_abnormal_social/conspecific_i | 1.70803483 |
42 | MP0001188_hyperpigmentation | 1.62815004 |
43 | MP0002067_abnormal_sensory_capabilities | 1.59279039 |
44 | MP0002184_abnormal_innervation | 1.58418879 |
45 | MP0002733_abnormal_thermal_nociception | 1.56923313 |
46 | MP0001970_abnormal_pain_threshold | 1.51213831 |
47 | MP0002735_abnormal_chemical_nociception | 1.46043261 |
48 | MP0000631_abnormal_neuroendocrine_gland | 1.42513395 |
49 | MP0003123_paternal_imprinting | 1.37169907 |
50 | MP0010386_abnormal_urinary_bladder | 1.37094993 |
51 | MP0003122_maternal_imprinting | 1.32515288 |
52 | MP0000013_abnormal_adipose_tissue | 1.31110264 |
53 | MP0005248_abnormal_Harderian_gland | 1.29676668 |
54 | MP0004145_abnormal_muscle_electrophysio | 1.28780463 |
55 | MP0005379_endocrine/exocrine_gland_phen | 1.28014793 |
56 | MP0000920_abnormal_myelination | 1.27937314 |
57 | MP0002822_catalepsy | 1.27666532 |
58 | MP0002882_abnormal_neuron_morphology | 1.27524541 |
59 | MP0004043_abnormal_pH_regulation | 1.26713692 |
60 | MP0005595_abnormal_vascular_smooth | 1.26184399 |
61 | MP0001963_abnormal_hearing_physiology | 1.25372090 |
62 | MP0003890_abnormal_embryonic-extraembry | 1.25267077 |
63 | MP0001485_abnormal_pinna_reflex | 1.25093112 |
64 | MP0004142_abnormal_muscle_tone | 1.23564937 |
65 | MP0002163_abnormal_gland_morphology | 1.23056582 |
66 | MP0002928_abnormal_bile_duct | 1.21694947 |
67 | MP0003329_amyloid_beta_deposits | 1.19826804 |
68 | MP0004924_abnormal_behavior | 1.19469882 |
69 | MP0005386_behavior/neurological_phenoty | 1.19469882 |
70 | MP0000026_abnormal_inner_ear | 1.17765979 |
71 | MP0002234_abnormal_pharynx_morphology | 1.17333089 |
72 | MP0005551_abnormal_eye_electrophysiolog | 1.13343075 |
73 | MP0008875_abnormal_xenobiotic_pharmacok | 1.13026772 |
74 | MP0003633_abnormal_nervous_system | 1.12897102 |
75 | MP0002066_abnormal_motor_capabilities/c | 1.12513781 |
76 | MP0002638_abnormal_pupillary_reflex | 1.10080873 |
77 | MP0003634_abnormal_glial_cell | 1.08693236 |
78 | MP0002132_abnormal_respiratory_system | 1.08673125 |
79 | MP0002233_abnormal_nose_morphology | 1.07446681 |
80 | MP0001502_abnormal_circadian_rhythm | 1.05933614 |
81 | MP0005623_abnormal_meninges_morphology | 1.01700156 |
82 | MP0006072_abnormal_retinal_apoptosis | 1.00834326 |
83 | MP0002938_white_spotting | 1.00145704 |
84 | MP0000955_abnormal_spinal_cord | 0.99408043 |
85 | MP0002752_abnormal_somatic_nervous | 0.98122132 |
86 | MP0004858_abnormal_nervous_system | 0.98009252 |
87 | MP0008874_decreased_physiological_sensi | 0.94543304 |
88 | MP0004885_abnormal_endolymph | 0.93901527 |
89 | MP0003938_abnormal_ear_development | 0.91339480 |
90 | MP0002152_abnormal_brain_morphology | 0.90818118 |
91 | MP0003698_abnormal_male_reproductive | 0.90417281 |
92 | MP0008569_lethality_at_weaning | 0.88739426 |
93 | MP0002876_abnormal_thyroid_physiology | 0.88541895 |
94 | MP0005195_abnormal_posterior_eye | 0.86239034 |
95 | MP0005171_absent_coat_pigmentation | 0.85172721 |
96 | MP0003861_abnormal_nervous_system | 0.84842469 |
97 | MP0002229_neurodegeneration | 0.84687818 |
98 | MP0005451_abnormal_body_composition | 0.82833321 |
99 | MP0003631_nervous_system_phenotype | 0.82741728 |
100 | MP0001986_abnormal_taste_sensitivity | 0.82605470 |
101 | MP0002277_abnormal_respiratory_mucosa | 0.80228093 |
102 | MP0004811_abnormal_neuron_physiology | 0.80197519 |
103 | MP0000462_abnormal_digestive_system | 0.79402653 |
104 | MP0002160_abnormal_reproductive_system | 0.79019282 |
105 | MP0009250_abnormal_appendicular_skeleto | 0.77602554 |
106 | MP0006035_abnormal_mitochondrial_morpho | 0.77433200 |
107 | MP0001346_abnormal_lacrimal_gland | 0.76415759 |
108 | MP0003119_abnormal_digestive_system | 0.76348046 |
109 | MP0002069_abnormal_eating/drinking_beha | 0.75614169 |
110 | MP0000566_synostosis | 0.75371499 |
111 | MP0010030_abnormal_orbit_morphology | 0.74557836 |
112 | MP0000751_myopathy | 0.72826200 |
113 | MP0001727_abnormal_embryo_implantation | 0.71734142 |
114 | MP0001177_atelectasis | 0.71688203 |
115 | MP0005253_abnormal_eye_physiology | 0.69009766 |
116 | MP0001664_abnormal_digestion | 0.68186697 |
117 | MP0008872_abnormal_physiological_respon | 0.67905778 |
118 | MP0004133_heterotaxia | 0.67855279 |
119 | MP0000049_abnormal_middle_ear | 0.67424016 |
120 | MP0002653_abnormal_ependyma_morphology | 0.67360794 |
121 | MP0003137_abnormal_impulse_conducting | 0.67082583 |
122 | MP0008877_abnormal_DNA_methylation | 0.67062188 |
123 | MP0005084_abnormal_gallbladder_morpholo | 0.62989291 |
124 | MP0002837_dystrophic_cardiac_calcinosis | 0.62787342 |
125 | MP0002102_abnormal_ear_morphology | 0.62182778 |
126 | MP0000604_amyloidosis | 0.60191027 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Abnormal ciliary motility (HP:0012262) | 6.68072541 |
2 | Abnormal respiratory motile cilium physiology (HP:0012261) | 6.34768783 |
3 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 5.91812944 |
4 | Rhinitis (HP:0012384) | 5.66227008 |
5 | Abnormal respiratory motile cilium morphology (HP:0005938) | 5.62005009 |
6 | Abnormal respiratory epithelium morphology (HP:0012253) | 5.62005009 |
7 | Absent/shortened dynein arms (HP:0200106) | 4.74813620 |
8 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 4.74813620 |
9 | Focal motor seizures (HP:0011153) | 4.63912305 |
10 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 4.16471039 |
11 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 4.16471039 |
12 | Retinal dysplasia (HP:0007973) | 3.66290266 |
13 | Myokymia (HP:0002411) | 3.44557364 |
14 | Abnormality of the corticospinal tract (HP:0002492) | 3.35684008 |
15 | Abnormality of midbrain morphology (HP:0002418) | 3.23850010 |
16 | Molar tooth sign on MRI (HP:0002419) | 3.23850010 |
17 | Bronchiectasis (HP:0002110) | 3.06707899 |
18 | Median cleft lip (HP:0000161) | 2.98637467 |
19 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.97451312 |
20 | Nephronophthisis (HP:0000090) | 2.90886744 |
21 | Neurofibrillary tangles (HP:0002185) | 2.87824694 |
22 | Sensory axonal neuropathy (HP:0003390) | 2.84338766 |
23 | Polyphagia (HP:0002591) | 2.79299010 |
24 | Cystic liver disease (HP:0006706) | 2.67458770 |
25 | Acute necrotizing encephalopathy (HP:0006965) | 2.63602737 |
26 | Chronic bronchitis (HP:0004469) | 2.63599866 |
27 | Focal seizures (HP:0007359) | 2.63338376 |
28 | Absent speech (HP:0001344) | 2.59630490 |
29 | Epileptic encephalopathy (HP:0200134) | 2.57180862 |
30 | Visual hallucinations (HP:0002367) | 2.53570763 |
31 | Pancreatic fibrosis (HP:0100732) | 2.51502422 |
32 | 3-Methylglutaconic aciduria (HP:0003535) | 2.48275920 |
33 | Termporal pattern (HP:0011008) | 2.43377335 |
34 | Insidious onset (HP:0003587) | 2.43377335 |
35 | Medial flaring of the eyebrow (HP:0010747) | 2.43092739 |
36 | Atonic seizures (HP:0010819) | 2.41942149 |
37 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.40711719 |
38 | Mitochondrial inheritance (HP:0001427) | 2.39134645 |
39 | Gait imbalance (HP:0002141) | 2.38296485 |
40 | Type II lissencephaly (HP:0007260) | 2.37353767 |
41 | Sclerocornea (HP:0000647) | 2.35791764 |
42 | True hermaphroditism (HP:0010459) | 2.33754770 |
43 | Stomach cancer (HP:0012126) | 2.33611967 |
44 | Progressive cerebellar ataxia (HP:0002073) | 2.31878703 |
45 | Abnormal eating behavior (HP:0100738) | 2.30852921 |
46 | Aplasia of the phalanges of the hand (HP:0009802) | 2.30622763 |
47 | Aplasia involving bones of the extremities (HP:0009825) | 2.30622763 |
48 | Aplasia involving bones of the upper limbs (HP:0009823) | 2.30622763 |
49 | Hyperglycinemia (HP:0002154) | 2.29561071 |
50 | Febrile seizures (HP:0002373) | 2.27432022 |
51 | Abnormality of the renal medulla (HP:0100957) | 2.26672240 |
52 | Occipital encephalocele (HP:0002085) | 2.24438946 |
53 | Male infertility (HP:0003251) | 2.22150593 |
54 | Anencephaly (HP:0002323) | 2.21146694 |
55 | Congenital primary aphakia (HP:0007707) | 2.17942763 |
56 | Chronic hepatic failure (HP:0100626) | 2.16686330 |
57 | Generalized tonic-clonic seizures (HP:0002069) | 2.14161210 |
58 | Failure to thrive in infancy (HP:0001531) | 2.14056129 |
59 | Cerebral inclusion bodies (HP:0100314) | 2.12216894 |
60 | Increased intramyocellular lipid droplets (HP:0012240) | 2.11693918 |
61 | Absent septum pellucidum (HP:0001331) | 2.11437210 |
62 | Optic nerve hypoplasia (HP:0000609) | 2.11282676 |
63 | Renal Fanconi syndrome (HP:0001994) | 2.09833445 |
64 | Hemiparesis (HP:0001269) | 2.08508365 |
65 | Chronic sinusitis (HP:0011109) | 2.07262790 |
66 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.06706635 |
67 | Increased hepatocellular lipid droplets (HP:0006565) | 2.04831929 |
68 | Progressive macrocephaly (HP:0004481) | 2.04263799 |
69 | Congenital hepatic fibrosis (HP:0002612) | 2.02150406 |
70 | Acute encephalopathy (HP:0006846) | 2.01795788 |
71 | Nephrogenic diabetes insipidus (HP:0009806) | 1.99583926 |
72 | Vaginal atresia (HP:0000148) | 1.99519099 |
73 | Abnormality of permanent molar morphology (HP:0011071) | 1.99294258 |
74 | Abnormality of the dental root (HP:0006486) | 1.99294258 |
75 | Taurodontia (HP:0000679) | 1.99294258 |
76 | Abnormality of renal resorption (HP:0011038) | 1.98760557 |
77 | Spastic gait (HP:0002064) | 1.97866042 |
78 | Postaxial hand polydactyly (HP:0001162) | 1.97382392 |
79 | Genital tract atresia (HP:0001827) | 1.97174874 |
80 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 1.95914932 |
81 | Increased CSF lactate (HP:0002490) | 1.95824327 |
82 | Short tibia (HP:0005736) | 1.93903655 |
83 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 1.93401735 |
84 | Abnormality of the dental pulp (HP:0006479) | 1.92892241 |
85 | Septo-optic dysplasia (HP:0100842) | 1.92392865 |
86 | Stage 5 chronic kidney disease (HP:0003774) | 1.91559882 |
87 | Neuroendocrine neoplasm (HP:0100634) | 1.91506746 |
88 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 1.91210234 |
89 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 1.91210234 |
90 | Absence seizures (HP:0002121) | 1.90993063 |
91 | Nasal polyposis (HP:0100582) | 1.89938202 |
92 | Abnormal drinking behavior (HP:0030082) | 1.88877347 |
93 | Polydipsia (HP:0001959) | 1.88877347 |
94 | Broad foot (HP:0001769) | 1.88025432 |
95 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 1.87694228 |
96 | Infertility (HP:0000789) | 1.86588093 |
97 | Bifid tongue (HP:0010297) | 1.85543371 |
98 | Hepatocellular necrosis (HP:0001404) | 1.85468896 |
99 | Dialeptic seizures (HP:0011146) | 1.85337807 |
100 | Preaxial hand polydactyly (HP:0001177) | 1.85250286 |
101 | Specific learning disability (HP:0001328) | 1.85037799 |
102 | Urinary bladder sphincter dysfunction (HP:0002839) | 1.84486489 |
103 | Poor coordination (HP:0002370) | 1.83456493 |
104 | Pancreatic cysts (HP:0001737) | 1.83298525 |
105 | Tubulointerstitial nephritis (HP:0001970) | 1.82911636 |
106 | Hepatic necrosis (HP:0002605) | 1.82834538 |
107 | Optic disc pallor (HP:0000543) | 1.82703522 |
108 | Inability to walk (HP:0002540) | 1.82086064 |
109 | Male pseudohermaphroditism (HP:0000037) | 1.81941486 |
110 | Abnormality of the labia minora (HP:0012880) | 1.81416696 |
111 | Hyperglycinuria (HP:0003108) | 1.80960990 |
112 | Supernumerary spleens (HP:0009799) | 1.80861422 |
113 | Lipid accumulation in hepatocytes (HP:0006561) | 1.80188492 |
114 | Sleep apnea (HP:0010535) | 1.79355780 |
115 | Abnormality of molar (HP:0011077) | 1.79211955 |
116 | Abnormality of molar morphology (HP:0011070) | 1.79211955 |
117 | Abnormality of the septum pellucidum (HP:0007375) | 1.78869315 |
118 | Limb dystonia (HP:0002451) | 1.78073201 |
119 | Increased circulating renin level (HP:0000848) | 1.78073150 |
120 | Narrow forehead (HP:0000341) | 1.76203410 |
121 | Polyuria (HP:0000103) | 1.75190295 |
122 | Epileptiform EEG discharges (HP:0011182) | 1.74751029 |
123 | Atelectasis (HP:0100750) | 1.74433210 |
124 | Amblyopia (HP:0000646) | 1.74117029 |
125 | Postaxial foot polydactyly (HP:0001830) | 1.73966618 |
126 | Cerebral edema (HP:0002181) | 1.73780864 |
127 | Hypsarrhythmia (HP:0002521) | 1.73532233 |
128 | Anxiety (HP:0000739) | 1.73107042 |
129 | Abnormality of glycine metabolism (HP:0010895) | 1.70999420 |
130 | Abnormality of serine family amino acid metabolism (HP:0010894) | 1.70999420 |
131 | Confusion (HP:0001289) | 1.70470893 |
132 | Abnormality of the anterior horn cell (HP:0006802) | 1.69863316 |
133 | Degeneration of anterior horn cells (HP:0002398) | 1.69863316 |
134 | Lissencephaly (HP:0001339) | 1.69716532 |
135 | EEG with generalized epileptiform discharges (HP:0011198) | 1.69339937 |
136 | Oculomotor apraxia (HP:0000657) | 1.63983023 |
137 | Poor suck (HP:0002033) | 1.63508098 |
138 | Abnormality of the lower motor neuron (HP:0002366) | 1.62135643 |
139 | Renal salt wasting (HP:0000127) | 1.60633625 |
140 | Tubular atrophy (HP:0000092) | 1.58238274 |
141 | Exercise intolerance (HP:0003546) | 1.56259014 |
142 | Hypomagnesemia (HP:0002917) | 1.53790500 |
143 | Hyperphosphaturia (HP:0003109) | 1.52914726 |
144 | Abnormality of urine glucose concentration (HP:0011016) | 1.51288709 |
145 | Glycosuria (HP:0003076) | 1.51288709 |
146 | Abnormality of the renal cortex (HP:0011035) | 1.50762183 |
147 | Colon cancer (HP:0003003) | 1.50510916 |
148 | Prominent nasal bridge (HP:0000426) | 1.49652192 |
Rank | Gene Set | Z-score |
---|---|---|
1 | CAMKK2 | 5.78510079 |
2 | CAMK1D | 4.78993969 |
3 | CAMK1G | 4.18955984 |
4 | MAPK15 | 3.21836810 |
5 | CASK | 3.19604790 |
6 | EPHA4 | 2.70789149 |
7 | CAMKK1 | 2.58505320 |
8 | PNCK | 2.55878988 |
9 | MAP4K2 | 2.43805158 |
10 | NTRK3 | 2.35221705 |
11 | MAP3K9 | 2.18543441 |
12 | NTRK2 | 2.03611438 |
13 | DYRK2 | 1.91422340 |
14 | TNIK | 1.85474424 |
15 | BCKDK | 1.80807352 |
16 | ARAF | 1.74027762 |
17 | WNK4 | 1.71986153 |
18 | DYRK1B | 1.66819500 |
19 | MAP2K7 | 1.54739130 |
20 | NME1 | 1.54447571 |
21 | TRIM28 | 1.54175217 |
22 | STK39 | 1.50181515 |
23 | STK16 | 1.49268452 |
24 | DYRK3 | 1.48560691 |
25 | CAMK1 | 1.47650193 |
26 | FES | 1.44646899 |
27 | MAPKAPK5 | 1.40836136 |
28 | LIMK1 | 1.39533779 |
29 | NTRK1 | 1.37956794 |
30 | OXSR1 | 1.36172918 |
31 | RIPK4 | 1.29201051 |
32 | ADRBK2 | 1.27827599 |
33 | WNK3 | 1.25179730 |
34 | MARK1 | 1.23472331 |
35 | MAPK13 | 1.23220029 |
36 | MAP3K13 | 1.22621999 |
37 | MINK1 | 1.18283877 |
38 | FGR | 1.11595652 |
39 | PRKCG | 1.11424632 |
40 | BMPR1B | 1.09664273 |
41 | PRKD3 | 1.07821220 |
42 | MST4 | 1.06012966 |
43 | MUSK | 1.05971759 |
44 | SGK223 | 1.05591559 |
45 | SGK494 | 1.05591559 |
46 | MAP2K4 | 1.05111842 |
47 | CAMK2B | 1.04454310 |
48 | UHMK1 | 1.03827030 |
49 | PAK6 | 0.94562483 |
50 | WNK1 | 0.92482594 |
51 | CDK5 | 0.90364725 |
52 | MAP3K12 | 0.87592265 |
53 | CAMK2A | 0.86506529 |
54 | CDK3 | 0.84049894 |
55 | TNK2 | 0.83000466 |
56 | KSR2 | 0.82949558 |
57 | TIE1 | 0.82167711 |
58 | PKN1 | 0.81753382 |
59 | TESK1 | 0.81360651 |
60 | GRK5 | 0.81030279 |
61 | VRK2 | 0.78319731 |
62 | ADRBK1 | 0.76992980 |
63 | CAMK2G | 0.76645576 |
64 | MAP3K4 | 0.76326047 |
65 | PRKCI | 0.76057685 |
66 | TYRO3 | 0.74853142 |
67 | ERBB3 | 0.74414864 |
68 | LRRK2 | 0.73566150 |
69 | ROCK2 | 0.72954874 |
70 | PHKG1 | 0.72510415 |
71 | PHKG2 | 0.72510415 |
72 | CDK19 | 0.69553431 |
73 | PRKCE | 0.69147688 |
74 | CSNK1G3 | 0.69100628 |
75 | FRK | 0.68736000 |
76 | CAMK2D | 0.66985341 |
77 | PAK3 | 0.65780149 |
78 | VRK1 | 0.65645783 |
79 | CAMK4 | 0.65187548 |
80 | GRK1 | 0.63687234 |
81 | FGFR2 | 0.63027576 |
82 | RAF1 | 0.62845636 |
83 | BMPR2 | 0.62511788 |
84 | PLK1 | 0.58972302 |
85 | NEK1 | 0.58779735 |
86 | CSNK1A1L | 0.58681475 |
87 | CSNK1G2 | 0.57892267 |
88 | PRKCZ | 0.57403428 |
89 | PRPF4B | 0.56935402 |
90 | KSR1 | 0.55914981 |
91 | MARK2 | 0.53786826 |
92 | SGK2 | 0.53566812 |
93 | PINK1 | 0.53556027 |
94 | CDK8 | 0.53210620 |
95 | CDK15 | 0.51726033 |
96 | SIK2 | 0.51604436 |
97 | CDK18 | 0.50477677 |
98 | LMTK2 | 0.50304205 |
99 | CSNK1E | 0.50246804 |
100 | PRKG2 | 0.50132207 |
101 | DDR2 | 0.49122547 |
102 | CDK14 | 0.48385780 |
103 | PRKG1 | 0.46903155 |
104 | ZAK | 0.46527942 |
105 | PLK2 | 0.45879243 |
106 | MAP3K7 | 0.44656353 |
107 | IRAK2 | 0.44639498 |
108 | PRKACA | 0.44049472 |
109 | CDC42BPA | 0.43980489 |
110 | RPS6KA5 | 0.43703008 |
111 | BRSK1 | 0.43668742 |
112 | CDK11A | 0.43598160 |
113 | EPHA2 | 0.43339000 |
114 | EPHB2 | 0.43314802 |
115 | IRAK1 | 0.43280134 |
116 | PRKACB | 0.42713108 |
117 | PTK2B | 0.42223794 |
118 | CSNK1G1 | 0.40942273 |
119 | PRKAA1 | 0.39956448 |
120 | PIM2 | 0.39954564 |
121 | DAPK2 | 0.39736816 |
122 | SGK1 | 0.38143762 |
123 | INSRR | 0.38047873 |
124 | PRKDC | 0.38036108 |
125 | CCNB1 | 0.37966394 |
126 | STK11 | 0.36223189 |
127 | NEK6 | 0.34826461 |
128 | BRAF | 0.33479628 |
129 | FYN | 0.33423108 |
130 | DYRK1A | 0.33200345 |
131 | BCR | 0.31520743 |
132 | PRKCH | 0.31432893 |
133 | AURKA | 0.27254433 |
134 | PRKCA | 0.27060862 |
135 | MYLK | 0.26394264 |
136 | MAP3K1 | 0.25007436 |
137 | CSNK1A1 | 0.24062864 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 3.74432472 |
2 | Nicotine addiction_Homo sapiens_hsa05033 | 3.70193982 |
3 | Parkinsons disease_Homo sapiens_hsa05012 | 2.81665174 |
4 | Olfactory transduction_Homo sapiens_hsa04740 | 2.68794577 |
5 | Alzheimers disease_Homo sapiens_hsa05010 | 2.53167370 |
6 | GABAergic synapse_Homo sapiens_hsa04727 | 2.38515564 |
7 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.34602472 |
8 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.28421376 |
9 | Huntingtons disease_Homo sapiens_hsa05016 | 2.26767968 |
10 | Circadian entrainment_Homo sapiens_hsa04713 | 2.17513161 |
11 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.12905268 |
12 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 2.04508212 |
13 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 2.04037870 |
14 | Morphine addiction_Homo sapiens_hsa05032 | 2.03563133 |
15 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.96942265 |
16 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.94161716 |
17 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.93938396 |
18 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.92577123 |
19 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.87166126 |
20 | Taste transduction_Homo sapiens_hsa04742 | 1.85981258 |
21 | Salivary secretion_Homo sapiens_hsa04970 | 1.84998667 |
22 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.83250804 |
23 | Insulin secretion_Homo sapiens_hsa04911 | 1.82992069 |
24 | Sulfur relay system_Homo sapiens_hsa04122 | 1.73657340 |
25 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.72156804 |
26 | Cocaine addiction_Homo sapiens_hsa05030 | 1.56957143 |
27 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.56399381 |
28 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.54341308 |
29 | Protein export_Homo sapiens_hsa03060 | 1.52641906 |
30 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.52320879 |
31 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.52065102 |
32 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.51375263 |
33 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.51351360 |
34 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.50078822 |
35 | Renin secretion_Homo sapiens_hsa04924 | 1.48620142 |
36 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.46752482 |
37 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.46015107 |
38 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.45672451 |
39 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.45237198 |
40 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.42668960 |
41 | Long-term potentiation_Homo sapiens_hsa04720 | 1.36362775 |
42 | Peroxisome_Homo sapiens_hsa04146 | 1.36127881 |
43 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.36064438 |
44 | Phototransduction_Homo sapiens_hsa04744 | 1.34638094 |
45 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.34513857 |
46 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.32155911 |
47 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.31944455 |
48 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.28718044 |
49 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.26540876 |
50 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.24409706 |
51 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.24112160 |
52 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.19400495 |
53 | Long-term depression_Homo sapiens_hsa04730 | 1.16805545 |
54 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.16464384 |
55 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.15759976 |
56 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.14259499 |
57 | Histidine metabolism_Homo sapiens_hsa00340 | 1.11941384 |
58 | Ribosome_Homo sapiens_hsa03010 | 1.10711579 |
59 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.07017604 |
60 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.06847273 |
61 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.06690353 |
62 | Axon guidance_Homo sapiens_hsa04360 | 1.02856804 |
63 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.98147852 |
64 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.90874287 |
65 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.89317176 |
66 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.88936235 |
67 | Prion diseases_Homo sapiens_hsa05020 | 0.88662369 |
68 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.87177291 |
69 | Gap junction_Homo sapiens_hsa04540 | 0.86778072 |
70 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.85520933 |
71 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.83735146 |
72 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.83166184 |
73 | Melanogenesis_Homo sapiens_hsa04916 | 0.82022524 |
74 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.81534279 |
75 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.81478619 |
76 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.80767502 |
77 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.80507788 |
78 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.80015254 |
79 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.79405815 |
80 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.76823216 |
81 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.76804110 |
82 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.76010806 |
83 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.75572280 |
84 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.75390065 |
85 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.72908385 |
86 | Mineral absorption_Homo sapiens_hsa04978 | 0.72196792 |
87 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.71853892 |
88 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.71021947 |
89 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.69989648 |
90 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.69751830 |
91 | RNA polymerase_Homo sapiens_hsa03020 | 0.69400201 |
92 | Alcoholism_Homo sapiens_hsa05034 | 0.68728771 |
93 | Retinol metabolism_Homo sapiens_hsa00830 | 0.67225372 |
94 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.67175318 |
95 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.67000862 |
96 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.65492925 |
97 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.65120395 |
98 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.64985459 |
99 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.63180477 |
100 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.62696445 |
101 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.62102457 |
102 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.61942092 |
103 | Carbon metabolism_Homo sapiens_hsa01200 | 0.61461675 |
104 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.61450605 |
105 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.60301679 |
106 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.55763940 |
107 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.55524080 |
108 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.54574591 |
109 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.53876494 |
110 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.53012314 |
111 | Bile secretion_Homo sapiens_hsa04976 | 0.51795117 |
112 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.51342314 |
113 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.51278981 |
114 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.50155087 |
115 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.48720545 |
116 | Purine metabolism_Homo sapiens_hsa00230 | 0.48689648 |
117 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.47545853 |
118 | RNA degradation_Homo sapiens_hsa03018 | 0.46398098 |
119 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.45577260 |
120 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.42689220 |
121 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.42639372 |
122 | Tight junction_Homo sapiens_hsa04530 | 0.42502144 |
123 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.40765065 |
124 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.40729902 |
125 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.40567732 |
126 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.39568416 |
127 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.37752097 |
128 | Phagosome_Homo sapiens_hsa04145 | 0.37289228 |
129 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.35898465 |
130 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.34362910 |
131 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.33113766 |
132 | Homologous recombination_Homo sapiens_hsa03440 | 0.32302382 |
133 | Metabolic pathways_Homo sapiens_hsa01100 | 0.30559494 |
134 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.29840767 |
135 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.28209029 |
136 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.28161765 |
137 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.27331711 |
138 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.26426638 |
139 | Circadian rhythm_Homo sapiens_hsa04710 | 0.25979939 |
140 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.23904507 |
141 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.20637100 |
142 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.20608928 |
143 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.20394501 |